Literature DB >> 16700321

Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.

Eliana Di Battista1, Arturo Naselli, Sara Queirolo, Federica Gallarotti, Maria Luisa Garré, Claudia Milanaccio, Armando Cama.   

Abstract

OBJECTIVE: To evaluate growth and endocrine features in children with craniopharyngioma who were treated and followed up by a single institution between 1976 and 2004. PATIENTS: The records of 32 children, 18 males and 14 females, were evaluated. The mean follow-up period was 6.3 years.
RESULTS: At presentation, the most common symptoms were headache, nausea and vomiting, visual impairment, and neurological changes. Some patients presented signs or symptoms of isolated or combined endocrine disorder (five polyuria and polydipsia, five growth failure, two precocious puberty, eight obesity or overweight). After tumour treatment, multiple pituitary hormonal deficiencies, especially growth hormone (GH) deficit (GHD) were found and required hormonal replacement therapy. Eight children grew normally without GH despite GHD. Hypothalamic involvement was observed in ten patients; obesity was frequent and was often associated with hyperinsulinism and hyperphagia.
CONCLUSION: Anterior and posterior pituitary deficiencies following surgery are present in all patients. The growth pattern is heterogeneous.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16700321

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

1.  Hyperinsulinemia may promote growth without GH in children after resection of suprasellar brain tumors.

Authors:  Hideyuki Iwayama; Takashi Kamijo; Norishi Ueda
Journal:  Endocrine       Date:  2011-06-03       Impact factor: 3.633

2.  Combined endoscopic and microscopic management of pediatric pituitary region tumors through one nostril: technical note with case illustrations.

Authors:  James L Frazier; Kaisorn Chaichana; George I Jallo; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2008-09-04       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.